Institutional Ownership
Kymera Therapeutics Inc
CUSIP 501575104COMKYMRQ1 2026
13D / 13G Filings
56
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
17.9%
Max % of class reported
Institutional Holders
248
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
56 filings · latest Feb 10, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 10, 2026 | Wellington Management Group LLP | 13G/A | 5.5% | 4.41M | SEC |
| 2 | Jan 8, 2026 | Fmr LLC | 13G/A | 11.2% | 8.93M | SEC |
| 3 | Dec 15, 2025 | Biotechnology Value Fund L P | 13D/A | 8.5% | — | SEC |
| 4 | Dec 11, 2025 | Baker Bros. Advisors LP | 13D/A | 10.9% | — | SEC |
| 5 | Nov 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 7.1% | 5.10M | SEC |
| 6 | Nov 5, 2025 | Fmr LLC | 13G/A | 8.2% | 5.88M | SEC |
| 7 | Aug 12, 2025 | Wellington Management Group LLP | 13G/A | 7.7% | 5.37M | SEC |
| 8 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 5.4% | 3.80M | SEC |
| 9 | Jun 30, 2025 | Baker Bros. Advisors LP | 13D/A | 9.5% | — | SEC |
| 10 | May 12, 2025 | Wellington Management Group LLP | 13G/A | 9.2% | 6.00M | SEC |
46 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Kymera Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 11.70M | $974.49M |
| 2 | Baker Bros. Advisors LP | 8.66M | $721.06M |
| 3 | Avoro Capital Advisors LLC | 7.47M | $622.57M |
| 4 | Bvf Inc/Il | 5.50M | $458.32M |
| 5 | Blackrock, Inc. | 5.06M | $421.52M |
| 6 | Atlas Venture Life Science Advisors, LLC | 4.58M | $381.30M |
| 7 | Wellington Management Group LLP | 3.89M | $323.97M |
| 8 | Siren, L.L.C. | 3.19M | $265.43M |
| 9 | State Street Corp | 2.39M | $199.04M |
| 10 | Capital Research Global Investors | 1.67M | $139.37M |